NPR logo

FDA Panel Rejects OTC Cholesterol Drug

  • Download
  • <iframe src="https://www.npr.org/player/embed/4285604/4285605" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
FDA Panel Rejects OTC Cholesterol Drug

Health Care

FDA Panel Rejects OTC Cholesterol Drug

FDA Panel Rejects OTC Cholesterol Drug

  • Download
  • <iframe src="https://www.npr.org/player/embed/4285604/4285605" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">

An FDA advisory panel rejects Merck's proposal to sell a cholesterol-lowering drug without a prescription. The FDA complained that a proposed label for the product is not informative enough, and that an OTC statin might create false confidence in consumers. NPR's Allison Aubrey reports.